AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Lilly, BMS, and Incyte Keep the AI Drug Discovery Deal Cycle Moving
A string of new deals from Lilly, Bristol Myers Squibb, and Incyte shows that AI integration is becoming a sustained biopharma trend rather than a one-off experiment. The question now is whether these deals will produce better drugs, or simply more collaboration headlines.
GEN: Lilly’s Expanded AI Footprint Shows Big Pharma Is Building Discovery Capacity Through Portfolios, Not Bets
Genetic Engineering & Biotechnology News frames Lilly’s latest collaboration as part of a broader expansion of its AI footprint. The significance is strategic: large pharma increasingly appears to be treating AI partnerships as a portfolio-building exercise across modalities and programs, rather than as isolated moonshots.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.